Oncolytic Viruses in the Treatment of Cancer: A Review of Current Strategies
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic Viruses in the Treatment of Cancer: A Review of Current Strategies
Authors
Keywords
-
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume 18, Issue 4, Pages 771-781
Publisher
Springer Nature
Online
2012-06-19
DOI
10.1007/s12253-012-9548-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncolytic Virus and Anti-4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
- (2012) L. B. John et al. CANCER RESEARCH
- Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
- (2012) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Immunotherapeutic potential of oncolytic vaccinia virus
- (2011) Steve H. Thorne IMMUNOLOGIC RESEARCH
- Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation
- (2011) S. Leveille et al. JOURNAL OF VIROLOGY
- Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription
- (2011) Feng Zhang et al. NATURE BIOTECHNOLOGY
- Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
- (2010) K.J. Harrington et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme
- (2010) Christian Goetz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: No shortcuts on the road to approval
- (2010) Caroline J. Breitbach et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
- (2010) Juan J Rojas et al. MOLECULAR THERAPY
- Oncolytic Viruses: An Approved Product on the Horizon?
- (2010) John Bell MOLECULAR THERAPY
- Protein transduction from retroviral Gag precursors
- (2010) Christine Voelkel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
- (2010) Han Hsi Wong et al. Viruses-Basel
- Increasing the Efficacy of Oncolytic Adenovirus Vectors
- (2010) Karoly Toth et al. Viruses-Basel
- Modification of mammalian reoviruses for use as oncolytic agents
- (2009) Diana JM Van Den Wollenberg et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma
- (2008) Ta-Chiang Liu et al. MOLECULAR THERAPY
- Chinese health biotech and the billion-patient market
- (2008) Sarah E Frew et al. NATURE BIOTECHNOLOGY
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
- (2008) Roberto Cattaneo et al. NATURE REVIEWS MICROBIOLOGY
- Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16
- (2008) M Aghi et al. ONCOGENE
- Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
- (2008) Irene Kuhn et al. PLoS One
- Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma
- (2007) Elżbieta Pajtasz-Piasecka et al. IMMUNOLOGY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now